Identification of S6K2 as a centrosome-located kinase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of S6K2 as a centrosome-located kinase

Published:2007-07-30 Issue:21 Volume:581 Page:4058-4064
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Rossi Rossella,Pester John M.,McDowell Mitch,Soza Samuela,Montecucco Alessandra,Lee-Fruman Kay K.

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference28 articles.

1. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression;Fingar;Oncogene,2004

2. S6K1(−/−)/S6K2(−/−) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway;Pende;Mol. Cell Biol.,2004

3. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1;Phin;Biochem. J.,2003

4. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase;Shima;Embo J.,1998

5. Characterization of S6K2, a novel kinase homologous to S6K1;Lee-Fruman;Oncogene,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines;Molecular Biology Reports;2024-01-28

2. Ribosomal Protein S6 Kinase 2 (RPS6KB2) is a Potential immunotherapeutic target for cancer with up-regulating pro-inflammatory cytokines;2023-08-25

3. S6K2 promises an important therapeutic potential for cancer;Future Oncology;2019-01

4. Expression and purification of p70ΔCT 104 S6 K, a 72 kDa c-terminal truncated p70S6 kinase-GST fusion protein in bacterial expression system;International Journal of Biological Macromolecules;2017-09

5. Autophagy and the Cell Cycle: A Complex Landscape;Frontiers in Oncology;2017-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3